CE-MS-based proteomics in biomarker discovery and clinical application-Reference-Cited by-同舟云学术

CE-MS-based proteomics in biomarker discovery and clinical application

Author:

Pontillo Claudia¹²,Filip Szymon²³,Borràs Daniel M.⁴⁵⁶,Mullen William⁷,Vlahou Antonia³⁸,Mischak Harald¹⁷

Affiliation:

1. Department of R&D; Mosaiques Diagnostics GmbH; Hanover Germany

2. Charité-Universitätsmedizin Berlin; Berlin Germany

3. Biotechnology Division; Biomedical Research Foundation; Academy of Athens; Athens Greece

4. Department of R&D; ServiceXS; Leiden The Netherlands

5. Institut National de la Santé et de la Recherche Médicale (INSERM); Institute of Cardiovascular and Metabolic Disease; Toulouse France

6. Université Toulouse III Paul-Sabatier; Toulouse France

7. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

8. School of Biomedical and Healthcare Sciences; Plymouth University; Plymouth UK

Funder

Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction

Clinical and system-omics for the identification of the Molecular Determinants of established Chronic Kidney Disease

Molecular Medicine for Bladder Cancer

Systems Biology to Identify Molecular Targets for Vascular Disease Treatment

Publisher

Wiley

Subject

Clinical Biochemistry

Reference91 articles.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献